Details of the Drug

General Information of Drug (ID: DM2IXK8)

Drug Name

ADS-5102

Synonyms

Amantadine hydrochloride; 1-Adamantanamine hydrochloride; 665-66-7; 1-Aminoadamantane hydrochloride; Amantadine HCl; Mydantane; Midantan; Midantane; Amazolon; adamantan-1-amine hydrochloride; 1-Adamantylamine hydrochloride; Adamantanamine hydrochloride; Virofral; Influenol; Trivaline; Viregyt; Virasol; Amantan; Virosol; Adamantylamine hydrochloride; Aminoadamantane hydrochloride; Adamantine hydrochloride; 1-Adamantanamine, hydrochloride; NSC 83653; EXP 105-1; Tricyclodecane; Mantadix; Exp-105-1; Amantadine (hydrochloride); UN

Indication

Disease Entry	ICD 11	Status	REF
Dyskinesia	MB47.4	Phase 3	[1]

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C10H18ClN
Canonical SMILES: C1C2CC3CC1CC(C2)(C3)N.Cl
InChI: InChI=1S/C10H17N.ClH/c11-10-4-7-1-8(5-10)3-9(2-7)6-10;/h7-9H,1-6,11H2;1H
InChIKey: WOLHOYHSEKDWQH-UHFFFAOYSA-N

Cross-matching ID

PubChem CID: 64150
ChEBI ID: CHEMBL2619
CAS Number: 665-66-7
TTD ID: D08MCS

Drug ADMET Endpoint Profile (DAE)^NEW

Click to Jump to the Detailed DAE Information of This Drug

Combinatorial Drugs (CBD)

Click to Jump to the Detailed CBD Information of This Drug

References

1	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)